Market Place
Sourcing Support
Curia Commits to Greenhouse Gas Emission Reductions
08 Oct 2024 //
CONTRACTPHARMA
Curia Commits to SBTi Net-Zero Standard
08 Oct 2024 //
GLOBENEWSWIRE
Bio X Cell Appoints Christopher Conway CEO
12 Aug 2024 //
CONTRACT PHARMA
Siegfried expands US reach with deal for Wisconsin facility
13 Jun 2024 //
FIERCE PHARMA
Curia And Carterra Host Biologics Symposium For Pacific Northwest Biotech
09 May 2024 //
PRESS RELEASE
Curia And Carterra Partner On Biologics Symposium
09 May 2024 //
GLOBENEWSWIRE
Curia Appoints Steve Lavezoli as Vice President, Biologics
23 Feb 2024 //
PRESS RELEASE
Curia Receives 2024 CDMO Leadership Award
05 Feb 2024 //
PRESS RELEASE
Curia Appoints Gerald Auer as Chief Financial Officer
16 Dec 2023 //
PRESS RELEASE
Curia Recognized on India Pharma Outlook`s 2023 List of Top 10 CDMO Companies
05 Dec 2023 //
PRESS RELEASE
Curia Supports Replicate Bioscience’s Phase 1 Clinical Trial of Novel Next-Generation RNA Vaccine
15 Sep 2023 //
PRESS RELEASE
Curia expands biologics capabilities with access to Touchlight’s doggybone DNA
25 Jul 2023 //
PRESS RELEASE
Curia wins 2023 Frost & Sullivan Customer Value Leadership Award
29 Jun 2023 //
GLOBENEWSWIRE
Curia Expands Cell Line Development Offering with CHOZN Platform
20 Jun 2023 //
PRESS RELEASE
Curia Collaborates with Corning to Advance Biopharmaceutical Continuous-Flow Development and Manufacturing Programs
23 Mar 2023 //
GLOBENEWSWIRE
Curia Appoints Philip Macnabb as Chief Executive Officer
16 Mar 2023 //
PRESS RELEASE
Curia Celebrates Ground-breaking Ceremony in Albuquerque
27 Oct 2022 //
PRESS RELEASE
Bausch Health`s Xifaxan is `prior art,` does not infringe Curia patents
19 Aug 2022 //
ENDPTS
Curia Names Niall Condon as President of Manufacturing Division
03 Aug 2022 //
CONTRACTPHARMA
Incannex Healthcare partners with R&D organisation Curia
02 Aug 2022 //
PROACTIVEINVESTORS
Curia and Replicate Bioscience Enter Strategic Collaboration
10 Jun 2022 //
PRESS RELEASE
Curia Adopts Berkeley Lights Platform to Expand its Ab Discovery Capabilities
07 Jun 2022 //
BUSINESSWIRE
Curia completes “Center of Speed” expansion with new GMP suites
28 Apr 2022 //
PRESS RELEASE
CURIA revolutionising patient participation in cancer treatment
31 Mar 2022 //
ECONOMICTIMES
Curia Global to double headcount in Hyderabad
28 Mar 2022 //
TIMESOFINDIA
Curia Global announces establishment of its Global Shared Services Centre
27 Mar 2022 //
TELANGANATODAY
Curia Recognized on Forbes America’s Best Employers 2022 List
24 Mar 2022 //
PRESS RELEASE
Major Bioscience Company Expands with the Help of State Funds
24 Mar 2022 //
GLOBENEWSWIRE
Curia Enters Agreement with U.S. Govt to Expand Sterile Fill-Finish Capability
09 Mar 2022 //
BUSINESSWIRE
Integrity Bio and LakePharma Become Curia
14 Feb 2022 //
PRESS RELEASE
Curia Launches Comprehensive mRNA Offering
22 Dec 2021 //
CONTRACTPHARMA
Curia Unveils Comprehensive mRNA Solution
22 Dec 2021 //
PRESS RELEASE
Nalu Bio Secures Global Supply Chain to Chemically Synthesize CBD
26 Oct 2021 //
PRNEWSWIRE
Curia Completes Acquisition of LakePharma
02 Sep 2021 //
PRESS RELEASE
Curia to Expand U.S. Commercial Manufacturing Capability
19 Aug 2021 //
CONTRACT PHARMA
Curia Completes Acquisition of Integrity Bio
04 Aug 2021 //
BUSINESSWIRE
Curia is making a major play at biologics with two new buyouts
22 Jul 2021 //
FIERCEPHARMA
Curia acquires the American company LakePharma
15 Jul 2021 //
BUSINESS WIRE
Curia to Acquire US-Based LakePharm
14 Jul 2021 //
PRESS RELEASE
Curia to Acquire US-Based LakePharma, Expanding End-to-End R&D Capabilities and Scale for Biologics
14 Jul 2021 //
PRESS RELEASE
Curia is buying formulation and fill finish CDMO Integrity Bio
14 Jul 2021 //
FIERCEPHARMA
Curia to Acquire Integrity Bio
13 Jul 2021 //
BUSINESSWIRE
Curia to Acquire Integrity Bio, Expanding Biologic Formulation and Fill-Finish Capabilities
13 Jul 2021 //
PRESS RELEASE
